Dimensional Fund Advisors LP Purchases 313,227 Shares of Oscar Health, Inc. (NYSE:OSCR)

Dimensional Fund Advisors LP grew its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,448,703 shares of the company's stock after purchasing an additional 313,227 shares during the period. Dimensional Fund Advisors LP owned approximately 1.39% of Oscar Health worth $46,353,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in OSCR. 1492 Capital Management LLC purchased a new stake in Oscar Health during the fourth quarter valued at $440,000. Canada Pension Plan Investment Board increased its holdings in shares of Oscar Health by 510.3% in the 4th quarter. Canada Pension Plan Investment Board now owns 958,200 shares of the company's stock worth $12,878,000 after buying an additional 801,200 shares during the last quarter. Global Endowment Management LP raised its position in shares of Oscar Health by 11.8% during the 4th quarter. Global Endowment Management LP now owns 38,446 shares of the company's stock valued at $517,000 after buying an additional 4,045 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Oscar Health by 9,811.2% in the 4th quarter. NewEdge Advisors LLC now owns 99,112 shares of the company's stock valued at $1,332,000 after acquiring an additional 98,112 shares during the last quarter. Finally, Jump Financial LLC grew its position in Oscar Health by 57.4% in the fourth quarter. Jump Financial LLC now owns 562,376 shares of the company's stock worth $7,558,000 after acquiring an additional 204,985 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $20.21.

Oscar Health Trading Up 30.3 %

Shares of NYSE:OSCR traded up $3.96 during trading hours on Wednesday, hitting $17.03. 28,734,900 shares of the company's stock traded hands, compared to its average volume of 4,035,436. The firm has a market capitalization of $4.27 billion, a P/E ratio of -850.87 and a beta of 1.75. The business has a fifty day moving average price of $13.22 and a 200-day moving average price of $14.61. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the company posted $0.62 EPS. Oscar Health's quarterly revenue was up 42.2% on a year-over-year basis. Equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.